TNFRSF8 and lymphoma: CD30 CAR-T cells are based on the novel costimulatory combination CD28.OX40 showed vigorous anti-lymphoma activity in anaplastic large cell lymphoma xenograft immunodeficient mouse model, which has an excellent prospect in clinical application [64] (Fig. 2).